Silencing of Tet3 acts to decrease mRNA expression of OxPhos and other mitochondrial-related genes in N2A cells. by Valeria Leon Kropf (17797623)

The number of IHC ribbons in <i>Diap3</i>-overexpressing mice decreases significantly over time. by Cynthia J. Schoen (282812)

“…<p>(A) Means of IHC ribbons (and mean ± SEM) at 4, 8, 16, and 24 weeks are shown. …”

Loss of <i>Igfbp7</i> decreases the alveolar density of the mammary gland during the pregnancy and lactation. by Sumanta Chatterjee (519822)

“…<p>(A) Whole mount slides were prepared from inguinal glands extracted from the wild-type (+/+) or the <i>Igfbp7</i>-null (−/−) female mice during pregnancy days (PD) 9 and 16 and lactation days (LD) 1 and 3 as well as 3 weeks port partum (3WPP). …”

Sorafenib pretreatment accelerated tumor growth, promoted lung metastasis, and decreased overall survival in nude mice. by Qiang-Bo Zhang (280959)

MR16-1 administration protocol. by Mitsutaka Yakabe (4782228)

Female bitransgenic mice show abnormal spontaneous physical activity and decreased oxygen consumption and body temperature. by Dongmei Wu (215055)

“…(B) Female bitransgenic mice had different physical activity pattern but similar daily physical activities when measured at 16 weeks of age through a 12-hour light/dark cycle using a comprehensive laboratory animal monitoring system (<i>n</i> = 7 for each group). …”

Decreased H3K4me3 in Δ cells is not necessarily due to decreased RNA polymerase II loading () ChIP analysis of H3K4me3 and RNA pol II levels on the locus by Klaas W. Mulder (12134)

“…ChIP efficiencies were 2–3% and 0.15–0.2% for H3K4me3 and 8WG16 antibodies, respectively. () Deletion of or lead to a similar decrease in H3K4me3 and transcript levels on the gene. …”

PSMα3N22Y has decreased chemotactic activity toward human neutrophils. by Gordon Y. C. Cheung (337723)

Intervention with MLKL decreased neutrophil death and protected mice against <i>E. coli</i> pneumonia. by Qinyu Luo (13000956)

Length distribution of the recently annotated ORFs of <i>B</i>. <i>japonicum</i> USDA 110. by Julia Hahn (3279486)

Complete vaccination coverage ranges by state coverage quartile for midpoints^a of Delta and Omicron predominant time periods. by Katherine G. Topf (14241763)

Tebuconazole decreased secreted Aβ42 levels in CHO PS1 ΔE9 cells but not in PS1 WT cells. by Yoon Young Cho (838272)

Cold-evoked behavioral switches and neuronal morphology after UV. by Heather N. Turner (6157268)

ZNF804a Regulates Expression of the Schizophrenia-Associated Genes PRSS16, COMT, PDE4B, and DRD2 by Matthew J. Girgenti (180992)

“…We demonstrate that expression of ZNF804a results in a significant increase in transcript levels of PRSS16 and COMT, relative to GFP transfected controls, and a statistically significant decrease in transcript levels of PDE4B and DRD2. …”

Loss of EBNA3C-CtBP binding decreases p300 occupancy at promoters of EBNA3C induced genes. by Makoto Ohashi (104612)

Annual treatment frequencies in all eyes. by Yasuyuki Sotani (20114144)

“…<p>The number of anti-VEGF treatments, STTA, MA-PC, PPV, and total treatments (mean ± SD) significantly decreased from 2.6 ± 1.6, 0.3 ± 0.8, 0.6 ± 0.8, 0.1 ± 0.3, and 3.7 ± 1.7 preoperatively to 0.8 ± 1.9, 0.0 ± 0.2, 0.3 ± 1.0, 0.0, and 1.2 ± 2.2; at year 2 to 0.7 ± 2.0, 0.1 ± 0.6, 0.0 ± 0.2, 0.0 ± 0.2, and 1.0 ± 2.1; and at year 3 to 0.9 ± 2.2, 0.0, 0.2 ± 1.0, 0.0 ± 0.2, and 1.1 ± 3.1 (Kruskal–Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …”

Inhibition of LDHA leads to decreased ATP, reduced AKT phosphorylation, and enhanced chemotherapy sensitivity to LBP in A549 and NCL-H1975 cells. by Siyu Yuan (7425719)

Annual number of outpatient visits in all eyes. by Yasuyuki Sotani (20114144)

“…<p>Mean visit frequency (mean ± standard deviation) significantly decreased from 11.5 ± 4.3 preoperatively to 8.8 ± 4.1, 5.0 ± 3.4, and 4.4 ± 3.2 visits in the first, second, and third postoperative years, respectively (Kruskal–Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …”

IL-10^−/− mice develop a less severe PCM associated with increased cellular immunity that results in decreased mortality rates. by Tânia A. Costa (440296)

Annual treatment frequencies in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

“…Mean outpatient visits in the recurrence group decreased from 13.6 ± 3.0 to 11.9 ± 5.0, 8.1 ± 3.9, and 7.8 ± 3.2 at 1, 2, and 3 years postoperatively, respectively (Kruskal-Wallis test, p < 0.001). …”